🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Type 2 Diabetes Mellitus
Eltero 5/Ertugliflozin acts as a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor, which lowers the renal glucose threshold. This results in a decrease in the plasma glucose concentration that exceeds the kidney's capacity to reabsorb glucose.
Cough, nasal congestion, sore throat, mouth ulcers, diarrhea, nausea, abdominal pain, constipation, weight loss, headache, back pain, joint pain, muscle pain, weakness, tremors.
Ertugliflozin is an SGLT2 inhibitor used to treat type 2 diabetes mellitus alone or in combination with other antidiabetic drugs.
Ertugliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces glucose reabsorption in the kidneys, leading to increased urinary glucose excretion.
Take orally once daily in the morning. Continue dietary regimen; manage missed doses appropriately.
May increase hypoglycemia risk when used with insulin or insulin secretagogues.
Severe renal impairment, end-stage renal disease (ESRD), dialysis, and history of serious hypersensitivity to ertugliflozin.
Pregnancy:
Lactation:
Store at or below 30°C in a dry place. Dispense only with a physician's prescription.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.